AI use in breast radiology increased cancer detection without higher recall rates, according to a 100,000+ case multicenter study.
Key Details
- 1Study conducted across four sites and included nine experienced breast radiologists.
- 2Over 100,000 digital breast tomosynthesis (DBT) exams analyzed.
- 3Results compared pre- and post-AI implementation: 54,000 exams before AI (339 true positives) vs. nearly 49,000 with AI (369 true positives).
- 4AI improved invasive and dense breast cancer detection and lowered average diagnosis stage.
- 5No increase in recall rates was observed with AI usage.
- 6The AI tool was provided by iCAD and the DBT system by GE HealthCare.
Why It Matters
Demonstrates AI's practical benefits in increasing breast cancer detection while maintaining recall rates, addressing workload and burnout concerns. This adds impactful real-world data supporting AI adoption in radiology practices.
Source
Radiology Business
Related News
•Radiology Business
GE HealthCare and RadNet Expand Global AI Mammography Partnership
GE HealthCare and RadNet are extending their partnership globally to offer AI-enhanced mammography systems.
•Radiology Business
NCCN Endorses AI Risk Tools for Breast Cancer Screening
NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
•AuntMinnie
FDA Rejects Petition to Exempt Radiology AI Devices from 510(k) Review
FDA denies a petition to exempt certain radiology AI software from 510(k) review, stressing ongoing regulatory oversight.